DEK and acute myeloid leukemia: It is known that the expression of the leukemogenic nuclear factor DEK-CAN activates the mTOR and STAT5 signaling [14, 15] strongly suggesting that activation of several signaling pathways contribute to the specific features by which DEK-CAN transforms cells in t(6;9)-AML.